Subtype
Colon Neoplasm
CI-CAN-00004992Explore in graph →
Non-malignant271 active trials5 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004992Explore in graph →
Clinical trials
1,560 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07012538 | RASi for Preventing Postoperative Recurrence of Stage II/III Colon Cancer(RAIPC) | completed | — | 2,640 | Fudan UniversityOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT04554836 | MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab | completed | Phase 2 | 6 | TheraOpOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT05405530 | Nasal Mask Kit in Gastrointestinal Endoscopy(NASO) | completed | N/A | 1,204 | RenJi HospitalOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT03037385 | Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors(ARROW) | completed | Phase 1 / Phase 2 | 590 | Hoffmann-La RocheINDUSTRY | 13 | May 31, 2025 | clinicaltrials |
| NCT06804876 | COMBO Endoscopy Oropharyngeal Airway in Sedated Gastrointestinal Endoscopy for Obese Patients | completed | Phase 2 | 107 | Zhejiang UniversityOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT02138617 | Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer | completed | Phase 2 | 100 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 18, 2025 | clinicaltrials |
| NCT03867409 | The United States Healthy Living Study | completed | N/A | 2,105 | University of FloridaOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT05658263 | Bacterial Intestinal Gut Modification Around Cancer Surgery (BIG MACS) Diet | completed | Early Phase 1 | 14 | University of MinnesotaOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT06957574 | Erector Spinae Plane Block as Analgesia in Patients for Colectomy | completed | N/A | 60 | Suez Canal UniversityOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT03407417 | A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary Care | completed | N/A | 960 | University of FloridaOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT01972737 | Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer | completed | Phase 1 | 10 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT02632448 | A Study of LY2880070 in Participants With Advanced or Metastatic Cancer | completed | Phase 1 / Phase 2 | 229 | Esperas Pharma Inc.OTHER | 4 | May 2, 2025 | clinicaltrials |
| NCT06573424 | Tirellizumab+Anlotinib VS Anlotinib for MSS-type CRC | completed | — | 124 | fan liOTHER | 1 | May 1, 2025 | clinicaltrials |
| NCT06950996 | A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum | completed | — | 300 | Instituto de Investigacion Sanitaria La FeOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT05500248 | Artificial Intelligence for Leaving in Situ Colorectal Polyps. | completed | N/A | 919 | University of Roma La SapienzaOTHER | 1 | Apr 18, 2025 | clinicaltrials |
| NCT02990481 | A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | Toray Industries, IncINDUSTRY | 2 | Apr 16, 2025 | clinicaltrials |
| NCT06324409 | ImmigrantScreen Telephone Reminder Trial in Colorectal Cancer Screening | completed | N/A | 400 | Norwegian Institute of Public HealthOTHER_GOV | 1 | Apr 15, 2025 | clinicaltrials |
| NCT04441580 | Assessing the Additional Neoplasia Yield of Computer-aided Colonoscopy in a Screening Setting(GENIAL-CO) | completed | N/A | 900 | Fondazione Poliambulanza Istituto OspedalieroOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT06910514 | Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions | completed | Phase 3 | 52 | Nakafarma S.L.INDUSTRY | 1 | Apr 9, 2025 | clinicaltrials |
| NCT04322539 | A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer(FRESCO-2) | completed | Phase 3 | 691 | Hutchison Medipharma LimitedINDUSTRY | 14 | Apr 4, 2025 | clinicaltrials |
| NCT05390398 | Study on Fatigue in Colorectal Cancer Survivors, a Lifestyle Intervention(SoFiT) | completed | N/A | 161 | Wageningen UniversityOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT06900686 | Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival | completed | — | 458 | Yanhong DengOTHER | 0 | Mar 28, 2025 | clinicaltrials |
| NCT03506321 | Comparison of the Benefit of Chromoendoscopy in Addition to High Definition White Light and Narrow Band Imaging for the Prediction of Submucosal Invasive Cancer in Colonic Lesions(LANS) | completed | N/A | 400 | Western Sydney Local Health DistrictOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT04138030 | Conventional Endoscopic Mucosal Resection Versus Cold Snare Endoscopic Mucosal Resection of Colonic Lateral Spreading Lesions - A Randomised Controlled Trial | completed | N/A | 182 | Western Sydney Local Health DistrictOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT05347745 | Therascreen® KRAS RGQ PCR Kit | completed | N/A | 219 | QIAGEN Gaithersburg, IncINDUSTRY | 1 | Mar 24, 2025 | clinicaltrials |
| NCT00200200 | Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer | completed | Phase 2 | 73 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06865586 | A Comparative Study of Tumor Specific Mesocolic Excision and Complete Mesocolic Excision for Right Sided Colon Cancer : Asian Multicenter Retrospective Study | completed | — | 3,326 | Asan Medical CenterOTHER | 1 | Mar 10, 2025 | clinicaltrials |
| NCT03058289 | A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6(IT-01) | completed | Phase 1 / Phase 2 | 111 | Intensity Therapeutics, Inc.INDUSTRY | 2 | Feb 27, 2025 | clinicaltrials |
| NCT06843954 | Impact of Vascular Endothelial Growth Factor Gene Polymorphisms on Bevacizumab Efficacy in a Sample of Iraqi Patients With Metastatic Colorectal Cancer | completed | Phase 4 | 157 | Mohammed Mahmood MohammedOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT04906343 | Endoscopic Surveillance in Serrated Polyposis Syndrome and Low-risk of Advanced Neoplasia | completed | N/A | 144 | Hospital Universitario de MóstolesOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT03992664 | Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment. | completed | N/A | 40 | Cyprus University of TechnologyOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT04186117 | Development of Clinical and Biological Database in Colorectal Cancer(CIRCUS) | completed | N/A | 89 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT05472753 | Dietary Supplement on the Intestinal Microbiota in Patients with Colon Cancer(TERATROFO) | completed | N/A | 75 | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT02861430 | Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular Biology(UNMASK) | completed | — | 48 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT01652196 | Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer | completed | Phase 2 | 56 | John HaysOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT01814501 | Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab | completed | Phase 2 | 16 | John HaysOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT05887531 | Abdominopelvic Cancer Prehabilitation | completed | N/A | 66 | Universitat Jaume IOTHER | 1 | Jan 29, 2025 | clinicaltrials |
| NCT03154190 | Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer | completed | N/A | 128 | Stanford UniversityOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06789224 | Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device(REMOVE) | completed | N/A | 136 | Lindis Bloodcare GmbHINDUSTRY | 1 | Jan 23, 2025 | clinicaltrials |
| NCT03730558 | ZETA : Prospective Observational Study(ZETA) | completed | — | 120 | Recherche cliniqueOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT05229822 | Bacterial Translocation Markers as Predictors of Infectious and Inflammatory Complications in Acute Bowel Obstruction | completed | — | 150 | Karaganda Medical UniversityOTHER | 1 | Jan 16, 2025 | clinicaltrials |
| NCT06764888 | ERAS in Elderly Colorectal Cancer Surgery(STOMIS-ERAS) | completed | — | 1,392 | Chang Gung Memorial HospitalOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT06753968 | The Role of Natural Orifice Specimen Extraction Surgery (NOSES) in Treating Right-sided Colon Cancer | completed | N/A | 349 | National Cancer Center, ChinaOTHER | 1 | Dec 31, 2024 | clinicaltrials |
| NCT04534218 | Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer(REPROGRAM-01) | completed | Phase 2 | 49 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Dec 20, 2024 | clinicaltrials |
| NCT02861300 | CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer | completed | Phase 1 / Phase 2 | 50 | David Bajor, MDOTHER | 1 | Dec 19, 2024 | clinicaltrials |
| NCT04028479 | The Registry of Oncology Outcomes Associated With Testing and Treatment(ROOT) | completed | — | 167 | Taproot HealthINDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT04682665 | Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases | completed | — | 81 | University of LeedsOTHER | 1 | Dec 4, 2024 | clinicaltrials |
| NCT05396807 | REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients(REVERT) | completed | N/A | 106 | University of Rome Tor VergataOTHER | 3 | Nov 29, 2024 | clinicaltrials |
| NCT03436563 | M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability | completed | Phase 1 / Phase 2 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 27, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Jun 10, 2025source: clinicaltrials